Skip to content

Laser CO2 Versus TENS After Reconstruction of the Rotator Cuff

Light Amplification by Simulated Emission Radiation Carbon Dioxide (Laser CO2) Versus Transcutaneous Electrical Stimulation (TENS) for the Reduction of Pain in Patients After Reconstruction of the Rotator Cuff. A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01391000
Enrollment
70
Registered
2011-07-11
Start date
2011-07-31
Completion date
2013-11-30
Last updated
2018-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator Cuff Injury

Keywords

rotator cuff surgery, pain, exercise therapy

Brief summary

The purpose of this study is to evaluate the most effective method between Transcutaneous Electrical Stimulation and Light Amplification by Stimulated Emission of Radiation therapy carbon dioxide therapy for pain control in the post-surgical rehabilitation of patients treated with reconstruction of the rotator cuff.

Detailed description

To evaluate the most effective method between Transcutaneous Electrical Stimulation and Light Amplification by Stimulated Emission of Radiation therapy carbon dioxide for pain control in the post-surgical rehabilitation of patients treated with reconstruction of the rotator cuff and to evaluate, at the end of the rehabilitation period, the range of motion, the function gained and the quality of life comparatively in the two groups of patients treated with Transcutaneous Electrical Stimulation or Light Amplification by Stimulated Emission of Radiation therapy carbon dioxide therapy.

Interventions

PROCEDURELASER CO2

The therapy is performed with the patient sitting, place the unit high above the shoulder with the following indicators: through a pulsed 40 Hz, distance between device and patient 60 cm, 10x15 cm area of application, power 2W; energy between 10 and 15 J/cm2

PROCEDURETENS

Transcutaneous Electrical Nerve Application of Stimulation occurs through the use of No. 3 channels (long head of biceps area (CLB), the supraspinatus muscle area, the area medial border of the scapula. Duration: Twenty (20) minutes, mpulsi: 70 microsec, frequency: 100 Hz, intensity: between 20 and 40 mA.

Sponsors

Istituto Ortopedico Rizzoli
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* subjects after surgery for rotator cuff injury of traumatic and / or degenerative

Exclusion criteria

* concomitant fractures of the humerus, pace-maker, diseases for which treatments are contraindicated.

Design outcomes

Primary

MeasureTime frameDescription
Visual Analogue Scale Mean ScoreChange from baseline in pain at the end of the rehabilitation cycle (two weeks)To evaluate the analgesic efficacy of Light Amplification by Stimulated Emission of Radiation carbon dioxide therapy vs Transcutaneous Electrical Nerve Stimulator during the first cycle of rehabilitation through Visual Analogue Scale, calculating the mean score in values of beginning and end of daily treatment. The scale had values from 0 to 10 where zero represented no pain and 10 the worst possible pain. More than 3 means pain.

Secondary

MeasureTime frameDescription
Constant Murley Score for Range of Motion and Shoulder Function Assessment.Change from baseline in range of motion at the end of the rehabilitation cycle (two weeks)The Constant Murley scale had values from 0 to 100 where zero represented the worst possible range of motion and shoulder function and 100 the best.
Short Form 12-PCS for Quality of Life AssessmentChange from baseline in quality of life at the end of the rehabilitation cycle (two weeks)The SF-12 is weighted and summed to provide easily interpretable scales for physical and mental health. SF-12 score measures substantially limited physical disability, general well-being and the perception of one's state of health, (Physical Component Summary) and also measure the psychological attitude of the patient, the limitation in social and personal activities (Mental Component Summary). Physical and Mental Health Composite Scores are computed using the scores of twelve questions and range from 0 to 100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health.

Countries

Italy

Participant flow

Participants by arm

ArmCount
Laser CO2
LASER CO2: The therapy is performed with the patient sitting, place the unit high above the shoulder with the following indicators: through a pulsed 40 Hz, distance between device and patient 60 cm, 10x15 cm area of application, power 2W; energy between 10 and 15 J/cm2
33
TENS
TENS: Transcutaneous Electrical Nerve Application of Stimulation occurs through the use of No. 3 channels (long head of biceps area (CLB), the supraspinatus muscle area, the area medial border of the scapula. Duration: Twenty (20) minutes, mpulsi: 70 microsec, frequency: 100 Hz, intensity: between 20 and 40 mA.
35
Total68

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up20

Baseline characteristics

CharacteristicLaser CO2TENSTotal
Age, Continuous58 years
STANDARD_DEVIATION 9.2
61.6 years
STANDARD_DEVIATION 6.5
59.8 years
STANDARD_DEVIATION 7.8
Number of participants with Traumatic Lesion18 Participants12 Participants30 Participants
Sex: Female, Male
Female
13 Participants14 Participants27 Participants
Sex: Female, Male
Male
20 Participants21 Participants41 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 330 / 35
other
Total, other adverse events
0 / 330 / 35
serious
Total, serious adverse events
0 / 330 / 35

Outcome results

Primary

Visual Analogue Scale Mean Score

To evaluate the analgesic efficacy of Light Amplification by Stimulated Emission of Radiation carbon dioxide therapy vs Transcutaneous Electrical Nerve Stimulator during the first cycle of rehabilitation through Visual Analogue Scale, calculating the mean score in values of beginning and end of daily treatment. The scale had values from 0 to 10 where zero represented no pain and 10 the worst possible pain. More than 3 means pain.

Time frame: Change from baseline in pain at the end of the rehabilitation cycle (two weeks)

ArmMeasureValue (MEAN)
Laser CO2Visual Analogue Scale Mean Score1.40 units on a scale
TENSVisual Analogue Scale Mean Score1.20 units on a scale
Secondary

Constant Murley Score for Range of Motion and Shoulder Function Assessment.

The Constant Murley scale had values from 0 to 100 where zero represented the worst possible range of motion and shoulder function and 100 the best.

Time frame: Change from baseline in range of motion at the end of the rehabilitation cycle (two weeks)

ArmMeasureValue (MEAN)
Laser CO2Constant Murley Score for Range of Motion and Shoulder Function Assessment.42.12 units on a scale
TENSConstant Murley Score for Range of Motion and Shoulder Function Assessment.41.69 units on a scale
Secondary

Short Form 12-PCS for Quality of Life Assessment

The SF-12 is weighted and summed to provide easily interpretable scales for physical and mental health. SF-12 score measures substantially limited physical disability, general well-being and the perception of one's state of health, (Physical Component Summary) and also measure the psychological attitude of the patient, the limitation in social and personal activities (Mental Component Summary). Physical and Mental Health Composite Scores are computed using the scores of twelve questions and range from 0 to 100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health.

Time frame: Change from baseline in quality of life at the end of the rehabilitation cycle (two weeks)

ArmMeasureValue (MEAN)
Laser CO2Short Form 12-PCS for Quality of Life Assessment41.07 units on a scale
TENSShort Form 12-PCS for Quality of Life Assessment41.35 units on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026